Martha J Demski - Net Worth and Insider Trading

Martha J Demski Net Worth

The estimated net worth of Martha J Demski is at least $269,843 dollars as of 2024-11-13. Martha J Demski is the Director of Adamas Pharmaceuticals Inc and owns about 13,000 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $106,860. Martha J Demski is the Director of ADMA Biologics Inc and owns about 4,200 shares of ADMA Biologics Inc (ADMA) stock worth over $91,476. Martha J Demski is also the Director of Chimerix Inc and owns about 72,055 shares of Chimerix Inc (CMRX) stock worth over $71,507. Details can be seen in Martha J Demski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martha J Demski has not made any transactions after 2023-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Martha J Demski

To

Martha J Demski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martha J Demski owns 7 companies in total, including ADMA Biologics Inc (ADMA) , Chimerix Inc (CMRX) , and Adamas Pharmaceuticals Inc (ADMS) among others .

Click here to see the complete history of Martha J Demski’s form 4 insider trades.

Insider Ownership Summary of Martha J Demski

Ticker Comapny Transaction Date Type of Owner
ADMA ADMA Biologics Inc 2022-03-07 director
CMRX Chimerix Inc 2023-05-10 director
ADMS Adamas Pharmaceuticals Inc 2020-06-03 director
LIMIT LIMIT 2018-10-11 director
LIMIT LIMIT 2014-11-19 director
LIMIT LIMIT 2004-05-21 Vice President & CFO
LIMIT LIMIT 2023-08-31 director

Martha J Demski Latest Holdings Summary

Martha J Demski currently owns a total of 3 stocks. Among these stocks, Martha J Demski owns 13,000 shares of Adamas Pharmaceuticals Inc (ADMS) as of April 9, 2014, with a value of $106,860 and a weighting of 39.6%. Martha J Demski owns 4,200 shares of ADMA Biologics Inc (ADMA) as of September 11, 2020, with a value of $91,476 and a weighting of 33.9%. Martha J Demski also owns 72,055 shares of Chimerix Inc (CMRX) as of May 10, 2023, with a value of $71,507 and a weighting of 26.5%.

Latest Holdings of Martha J Demski

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADMS Adamas Pharmaceuticals Inc 2014-04-09 13,000 8.22 106,860
ADMA ADMA Biologics Inc 2020-09-11 4,200 21.78 91,476
CMRX Chimerix Inc 2023-05-10 72,055 0.99 71,507

Holding Weightings of Martha J Demski


Martha J Demski Form 4 Trading Tracker

According to the SEC Form 4 filings, Martha J Demski has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 0 shares on April 9, 2014, which brought Martha J Demski around $0.

According to the SEC Form 4 filings, Martha J Demski has made a total of 2 transactions in ADMA Biologics Inc (ADMA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ADMA Biologics Inc is the acquisition of 2,200 shares on September 11, 2020, which cost Martha J Demski around $5,038.

According to the SEC Form 4 filings, Martha J Demski has made a total of 5 transactions in Chimerix Inc (CMRX) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Chimerix Inc is the acquisition of 18,000 shares on May 10, 2023, which cost Martha J Demski around $19,980.

Insider Trading History of Martha J Demski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martha J Demski Trading Performance

GuruFocus tracks the stock performance after each of Martha J Demski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martha J Demski is -8.26%. GuruFocus also compares Martha J Demski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martha J Demski within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martha J Demski's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martha J Demski

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.56 LIMIT LIMIT LIMIT LIMIT LIMIT

Martha J Demski Ownership Network

Ownership Network List of Martha J Demski

No Data

Ownership Network Relation of Martha J Demski

Insider Network Chart

Martha J Demski Owned Company Details

What does ADMA Biologics Inc do?

Who are the key executives at ADMA Biologics Inc?

Martha J Demski is the director of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include director & President and CEO Adam S Grossman , EVP & CFO Brian Lenz , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

ADMA Biologics Inc (ADMA) Insider Trades Summary

Over the past 18 months, Martha J Demski made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 1,486,717 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 35,000 shares made by Young Kwon .

In summary, during the past 3 months, insiders sold 856,256 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 856,256 shares. During the past 18 months, 5,039,794 shares of ADMA Biologics Inc (ADMA) were sold and 155,000 shares were bought by its insiders, resulting in a net sale of 4,884,794 shares.

ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ADMA Biologics Inc Insider Transactions

No Available Data

Martha J Demski Mailing Address

Above is the net worth, insider trading, and ownership report for Martha J Demski. You might contact Martha J Demski via mailing address: 7770 Regents Road Suite 113-505, San Diego Ca 92122.